K
Keon Mahmoudi
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 13
Citations - 728
Keon Mahmoudi is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Stroke & Fluid-attenuated inversion recovery. The author has an hindex of 7, co-authored 11 publications receiving 439 citations. Previous affiliations of Keon Mahmoudi include Mount Sinai Hospital & Georgia Institute of Technology.
Papers
More filters
Journal ArticleDOI
Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy's history, efficacy and application in humans.
TL;DR: In this review, the application of MHT as a therapeutic modality for GBM will be discussed, its therapeutic efficacy, technical details, and major experimental and clinical findings will be reviewed and analysed.
Journal ArticleDOI
5-Aminolevulinic Acid Photodynamic Therapy for the Treatment of High-Grade Gliomas
Keon Mahmoudi,Katherine L. Garvey,Alexandros Bouras,Gwendolyn M. Cramer,H Stepp,J G Jesu Raj,Dominique Bozec,Theresa M. Busch,Constantinos G. Hadjipanayis,Constantinos G. Hadjipanayis +9 more
TL;DR: PDT remains a promising therapeutic approach that requires further study in high-grade gliomas and requires a better understanding of its mechanisms of action.
Journal ArticleDOI
COVID-19 Is an Independent Risk Factor for Acute Ischemic Stroke.
Puneet Belani,Javin Schefflein,Shingo Kihira,Brian Rigney,Bradley N. Delman,Keon Mahmoudi,J Mocco,Shahram Majidi,J. Yeckley,Amit Aggarwal,D. Lefton,Amish H. Doshi +11 more
TL;DR: It is demonstrated that CO VID-19 infection is significantly associated with imaging confirmation of acute ischemic stroke, and patients with COVID-19 should undergo more aggressive monitoring for stroke.
Journal ArticleDOI
Association of Coronavirus Disease (COVID-19) With Large Vessel Occlusion Strokes: A Case-Control Study.
Shingo Kihira,Javin Schefflein,Keon Mahmoudi,Brian Rigney,Bradley N. Delman,J Mocco,Amish H. Doshi,Puneet Belani +7 more
TL;DR: Patients with COVID-19 presenting with acute neurologic symptoms warrant a lower threshold for suspicion of large vessel stroke, and prompt workup for large vessels stroke is recommended.
Journal ArticleDOI
The application of magnetic nanoparticles for the treatment of brain tumors
TL;DR: The blood brain barrier (BBB) represents another challenge to the treatment of GBM tumors by preventing the accumulation of most chemotherapeutics into the brain to target the infiltrative cancer cells.